These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25824484)

  • 1. Rapid optimization of drug combinations for the optimal angiostatic treatment of cancer.
    Weiss A; Ding X; van Beijnum JR; Wong I; Wong TJ; Berndsen RH; Dormond O; Dallinga M; Shen L; Schlingemann RO; Pili R; Ho CM; Dyson PJ; van den Bergh H; Griffioen AW; Nowak-Sliwinska P
    Angiogenesis; 2015 Jul; 18(3):233-44. PubMed ID: 25824484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of ruthenium(II)-arene complex [Ru(η
    Berndsen RH; Weiss A; Abdul UK; Wong TJ; Meraldi P; Griffioen AW; Dyson PJ; Nowak-Sliwinska P
    Sci Rep; 2017 Feb; 7():43005. PubMed ID: 28223694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel method of screening combinations of angiostatics identifies bevacizumab and temsirolimus as synergistic inhibitors of glioma-induced angiogenesis.
    Dorrell MI; Kast-Woelbern HR; Botts RT; Bravo SA; Tremblay JR; Giles S; Wada JF; Alexander M; Garcia E; Villegas G; Booth CB; Purington KJ; Everett HM; Siles EN; Wheelock M; Silva JA; Fortin BM; Lowey CA; Hale AL; Kurz TL; Rusing JC; Goral DM; Thompson P; Johnson AM; Elson DJ; Tadros R; Gillette CE; Coopwood C; Rausch AL; Snowbarger JM
    PLoS One; 2021; 16(6):e0252233. PubMed ID: 34077449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiangiogenic and Anticancer Properties of Bifunctional Ruthenium(II)-p-Cymene Complexes: Influence of Pendant Perfluorous Chains.
    Nowak-Sliwinska P; Clavel CM; Păunescu E; te Winkel MT; Griffioen AW; Dyson PJ
    Mol Pharm; 2015 Aug; 12(8):3089-96. PubMed ID: 26158308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Phosphatidylinositol 3-Kinase Signaling Pathway for Therapeutic Enhancement of Vascular-Targeted Photodynamic Therapy.
    Kraus D; Palasuberniam P; Chen B
    Mol Cancer Ther; 2017 Nov; 16(11):2422-2431. PubMed ID: 28835385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
    Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
    Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-MUC1 monoclonal antibody (C595) and docetaxel markedly reduce tumor burden and ascites, and prolong survival in an in vivo ovarian cancer model.
    Wang L; Chen H; Pourgholami MH; Beretov J; Hao J; Chao H; Perkins AC; Kearsley JH; Li Y
    PLoS One; 2011; 6(9):e24405. PubMed ID: 21931707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of a mixture containing ascorbic acid, lysine, proline and green tea extract on critical parameters in angiogenesis.
    Roomi MW; Roomi N; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
    Oncol Rep; 2005 Oct; 14(4):807-15. PubMed ID: 16142336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Hedyotis Diffusa Willd extract on tumor angiogenesis.
    Lin J; Wei L; Xu W; Hong Z; Liu X; Peng J
    Mol Med Rep; 2011; 4(6):1283-8. PubMed ID: 21887465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
    Tian F; Zhang X; Tong Y; Yi Y; Zhang S; Li L; Sun P; Lin L; Ding J
    Cancer Biol Ther; 2005 Aug; 4(8):874-82. PubMed ID: 16082187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A streamlined search technology for identification of synergistic drug combinations.
    Weiss A; Berndsen RH; Ding X; Ho CM; Dyson PJ; van den Bergh H; Griffioen AW; Nowak-Sliwinska P
    Sci Rep; 2015 Sep; 5():14508. PubMed ID: 26416286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform.
    Liu Q; Zhang C; Ding X; Deng H; Zhang D; Cui W; Xu H; Wang Y; Xu W; Lv L; Zhang H; He Y; Wu Q; Szyf M; Ho CM; Zhu J
    Sci Rep; 2015 Jun; 5():11464. PubMed ID: 26088171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent preclinical impact of metronomic low-dose oral topotecan combined with the antiangiogenic drug pazopanib for the treatment of ovarian cancer.
    Hashimoto K; Man S; Xu P; Cruz-Munoz W; Tang T; Kumar R; Kerbel RS
    Mol Cancer Ther; 2010 Apr; 9(4):996-1006. PubMed ID: 20371722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Decade of Experience in Developing Preclinical Models of Advanced- or Early-Stage Spontaneous Metastasis to Study Antiangiogenic Drugs, Metronomic Chemotherapy, and the Tumor Microenvironment.
    Kerbel RS
    Cancer J; 2015; 21(4):274-83. PubMed ID: 26222079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy between angiostatin and endostatin: inhibition of ovarian cancer growth.
    Yokoyama Y; Dhanabal M; Griffioen AW; Sukhatme VP; Ramakrishnan S
    Cancer Res; 2000 Apr; 60(8):2190-6. PubMed ID: 10786683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of paclitaxel-mediated cytotoxicity in lung cancer cells by 17-allylamino geldanamycin: in vitro and in vivo analysis.
    Nguyen DM; Lorang D; Chen GA; Stewart JH; Tabibi E; Schrump DS
    Ann Thorac Surg; 2001 Aug; 72(2):371-8; discussion 378-9. PubMed ID: 11515869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The isoflavone metabolite 6-methoxyequol inhibits angiogenesis and suppresses tumor growth.
    Bellou S; Karali E; Bagli E; Al-Maharik N; Morbidelli L; Ziche M; Adlercreutz H; Murphy C; Fotsis T
    Mol Cancer; 2012 May; 11():35. PubMed ID: 22583931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irinotecan synergistically enhances the antiproliferative and proapoptotic effects of axitinib in vitro and improves its anticancer activity in vivo.
    Canu B; Fioravanti A; Orlandi P; Di Desidero T; Alì G; Fontanini G; Di Paolo A; Del Tacca M; Danesi R; Bocci G
    Neoplasia; 2011 Mar; 13(3):217-29. PubMed ID: 21390185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The soluble form of the cancer-associated L1 cell adhesion molecule is a pro-angiogenic factor.
    Friedli A; Fischer E; Novak-Hofer I; Cohrs S; Ballmer-Hofer K; Schubiger PA; Schibli R; Grünberg J
    Int J Biochem Cell Biol; 2009 Jul; 41(7):1572-80. PubMed ID: 19401151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with direct and indirect angiogenesis inhibition results in enhanced antiangiogenic and antitumor effects.
    Abdollahi A; Lipson KE; Sckell A; Zieher H; Klenke F; Poerschke D; Roth A; Han X; Krix M; Bischof M; Hahnfeldt P; Grone HJ; Debus J; Hlatky L; Huber PE
    Cancer Res; 2003 Dec; 63(24):8890-8. PubMed ID: 14695206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.